When asked by her attorney if she ever intentionally misled investors in failed blood-testing startup Theranos, Elizabeth Holmes confidently responded, "Never."
The assertion was the final question put to her on the stand, highlighting an overarching theme of her defense that Theranos was something she believed in, and that others had reason to believe in it too.
After seven days, Holmes' lawyers rested their case Wednesday in the disgraced CEO's criminal fraud trial, in which she's facing 11 counts of wire fraud and conspiracy to commit wire fraud. As the government won't bring rebuttal witnesses, closing arguments from each side are up next, which would likely start on Dec. 16, U.S. District Judge Edward Davila said.